Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Royalty Pharma plc | 191,803 | reported | 14 May 2026 | tx 12+241,606−51,011 |
| Praxis Precision Medicines, Inc. | 10,520 | reported | 26 Jun 2025 | tx 6+95,989 |
| Entasis Therapeutics Holdings Inc. | 7,500 | reported | 19 Jun 2019 | tx 2+22,500 |
| HUMAN GENOME SCIENCES INC | 4,166 | reported | 30 Jul 2012 | tx 9+64,500−23,500 |
| KV PHARMACEUTICAL CO /DE/ | 3,751 | reported | 10 Oct 2013 | tx 3+23,751 |
| WYETH | 0 | reported | 15 Oct 2009 | tx 20+152,750−462,414.47 |
| NanoString Technologies Inc | 0 | reported | 06 May 2024 | tx 32+233,038−106,864 |
| Zoetis Inc. | 0 | reported | 09 Mar 2026 | tx 60+67,527.36−56,600.02 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | SALE | Royalty Pharma plc | 3,045 | 53.00 USD | 10b5-1 |
| 09 Mar 2026 | GIFT | Zoetis Inc. | 1,213 | 0.00 USD | |
| 19 Feb 2026 | EXERCISE | Zoetis Inc. | 1,619 | — | |
| 19 Feb 2026 | OTHER | Zoetis Inc. | 406 | 127.28 USD | |
| 19 Feb 2026 | EXERCISE | Zoetis Inc. | 1,619.33 | — | deriv |
| 18 Feb 2026 | GRANT_AWARD | Zoetis Inc. | 1,936 | 0.00 USD | deriv |
| 08 Aug 2025 | CONVERSION | Royalty Pharma plc | 144,660 | 0.00 USD | |
| 11 Aug 2025 | SALE | Royalty Pharma plc | 33,500 | 36.23 USD | |
| 08 Aug 2025 | CONVERSION | Royalty Pharma plc | 14,466 | 0.00 USD | deriv |
| 26 Jun 2025 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 10,520 | 0.00 USD | deriv |
| 13 May 2025 | GRANT_AWARD | Royalty Pharma plc | 7,614 | 0.00 USD | |
| 19 Feb 2025 | GRANT_AWARD | Zoetis Inc. | 1,596 | 0.00 USD | deriv |
| 14 Feb 2025 | GIFT | Zoetis Inc. | 1,843 | 0.00 USD | |
| 08 Feb 2025 | EXERCISE | Zoetis Inc. | 1,225 | — | |
| 08 Feb 2025 | OTHER | Zoetis Inc. | 308 | 171.43 USD | |
| 08 Feb 2025 | EXERCISE | Zoetis Inc. | 1,225.4 | — | deriv |
| 06 Feb 2025 | EXERCISE | Zoetis Inc. | 1,236 | — | |
| 06 Feb 2025 | OTHER | Zoetis Inc. | 310 | 174.12 USD | |
| 06 Feb 2025 | EXERCISE | Zoetis Inc. | 1,236.21 | — | deriv |
| 07 Jun 2024 | GRANT_AWARD | Royalty Pharma plc | 9,293 | 0.00 USD | |
| 05 Jun 2024 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 8,566 | 0.00 USD | deriv |
| 06 May 2024 | EXERCISE | NanoString Technologies Inc | 41,133 | 0.00 USD | |
| 06 May 2024 | EXERCISE | NanoString Technologies Inc | 41,133 | 0.00 USD | deriv |
| 21 Feb 2024 | GIFT | Zoetis Inc. | 2,214 | 0.00 USD | |
| 10 Feb 2024 | EXERCISE | Zoetis Inc. | 1,463 | — |
2 purchases reported after at least 12 months of silence — most recent on 07 Mar 2023.